Cargando…
Magnetic resonance imaging markers for early diagnosis of Parkinson's disease☆
Parkinson's disease (PD) is a neurodegenerative disorder characterized by selective and progressive degeneration, as well as loss of dopaminergic neurons in the substantia nigra. In PD, approximately 60-70% of nigrostriatal neurons are degenerated and 80% of content of the striatal dopamine is...
Autores principales: | Marino, Silvia, Ciurleo, Rosella, Di Lorenzo, Giuseppe, Barresi, Marina, De Salvo, Simona, Giacoppo, Sabrina, Bramanti, Alessia, Lanzafame, Pietro, Bramanti, Placido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346987/ https://www.ncbi.nlm.nih.gov/pubmed/25745453 http://dx.doi.org/10.3969/j.issn.1673-5374.2012.08.009 |
Ejemplares similares
-
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson's Disease?
por: Ciurleo, Rosella, et al.
Publicado: (2014) -
Effect of MAO-B Inhibitors on Neurometabolic Profile of Patients Affected by Parkinson Disease: A Proton Magnetic Resonance Spectroscopy Study
por: Bonanno, Lilla, et al.
Publicado: (2022) -
The impact of SARS-COV2 infection on people in residential care with Parkinson Disease or parkinsonisms: Clinical case series study
por: Sorbera, Chiara, et al.
Publicado: (2021) -
Olfactory event-related potentials in a functionally anosmic patient
with arrested hydrocephalus
por: Caminiti, Fabrizia, et al.
Publicado: (2019) -
Parosmia and Neurological Disorders: A Neglected Association
por: Ciurleo, Rosella, et al.
Publicado: (2020)